Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors

被引:0
作者
M. Moegele
S. Buchholz
S. Seitz
Olaf Ortmann
机构
[1] University Medical Center Regensburg,Department of Obstetrics and Gynecology
来源
Archives of Gynecology and Obstetrics | 2012年 / 285卷
关键词
Breast cancer; Hormone therapy; Vaginal estrogen; Aromatase inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1397 / 1402
页数:5
相关论文
共 181 条
[21]  
Lusek R(2009)LIBERATE Study Group: safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double- blind, randomized, non inferiority trial Lancet Oncol. 10 135-535
[22]  
Berthold HK(2005)Menopausal hormone therapy after breast cancer: the Stockholm randomized trial J Natl Cancer Inst 97 533-93
[23]  
Tiaden JD(1997)Estrogen replacement therapy in women with prior diagnosis and treatment for breast cancer Gynecol Oncol 65 89-375
[24]  
Collins JA(1993)Hormone replacement therapy in previously treated breast cancer patients Am J Surg 165 372-1913
[25]  
Blake JM(1989)Hormone replacement therapy in women treated for breast cancer Eur J Cancer Clin Oncol 25 1909-61
[26]  
Crosignani PG(1993)Hormone replacement after breast cancer Lancet 342 60-72
[27]  
Farquhar CM(1995)A case-controlled study of combined continuous hormone replacement therapy amongst women with a personal history of breast cancer Menopause 2 67-151
[28]  
Marjoribanks J(1999)A case-control study of hormone replacement therapy after primary surgical breast cancer treatment Eur J Surg Oncol 25 146-1487
[29]  
Lethaby A(1999)Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively J Clin Oncol 17 1482-545
[30]  
Lamberts Q(2000)Breast cancer survival and hormone replacement therapy: a cohort analysis Am J Clin Oncol 23 541-299